XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 184 filers reported holding XENON PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 2.73 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,204,311 | +78.0% | 35,255 | +100.6% | 0.56% | +79.7% |
| Q2 2023 | $676,638 | -25.4% | 17,575 | -30.6% | 0.31% | -58.1% |
| Q1 2023 | $906,919 | -9.2% | 25,340 | 0.0% | 0.74% | +24.6% |
| Q4 2022 | $999,156 | +22.6% | 25,340 | +12.3% | 0.59% | +27.5% |
| Q3 2022 | $815,000 | +19.5% | 22,572 | +0.6% | 0.46% | +12.9% |
| Q2 2022 | $682,000 | -20.3% | 22,435 | -19.9% | 0.41% | -24.3% |
| Q1 2022 | $856,000 | -56.4% | 27,992 | -55.5% | 0.54% | -65.2% |
| Q4 2021 | $1,965,000 | +71.3% | 62,906 | -16.2% | 1.56% | +106.1% |
| Q3 2021 | $1,147,000 | +50.3% | 75,046 | +83.2% | 0.76% | +40.3% |
| Q2 2021 | $763,000 | +58.3% | 40,959 | -5.9% | 0.54% | +54.1% |
| Q3 2020 | $482,000 | +89.8% | 43,517 | +115.0% | 0.35% | +67.1% |
| Q2 2020 | $254,000 | – | 20,239 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 850,000 | $15,215,000 | 3.58% |
| ACUTA CAPITAL PARTNERS, LLC | 412,500 | $7,384,000 | 2.66% |
| BVF INC/IL | 3,481,778 | $62,324,000 | 2.34% |
| Soleus Capital Management, L.P. | 708,117 | $12,675,000 | 2.28% |
| COMMODORE CAPITAL LP | 301,392 | $5,395,000 | 2.15% |
| DAFNA Capital Management LLC | 406,535 | $7,277,000 | 1.73% |
| Parkman Healthcare Partners LLC | 374,395 | $6,702,000 | 1.56% |
| Avoro Capital Advisors LLC | 3,650,000 | $65,335,000 | 1.13% |
| KNOTT DAVID M | 144,101 | $2,579,000 | 1.10% |
| Orbimed Advisors | 2,497,917 | $44,713,000 | 0.42% |